Prevent Washington

Learning to live with COVID-19 It’s possible to achieve population or herd immunity from COVID-19 if we can drive the post-vaccination boosting immunity to levels that would prevent spread.

What Hutch coronavirus experts are saying about omicron Scientists at Fred Hutch are among the researchers worldwide taking a look at omicron, a new coronavirus variant, to learn how it might affect us. Here's what they're saying.

“I don’t think we’re going back to just ignoring people who are sick,” said Larry Corey, a virologist and past president of
Fred Hutch “Coming to school or coming to work and just assuming that no matter what, it’s not going to hurt you.” https://washingtonpost.com/health/2021/11/21/pandemic-antiviral-pills/
Washington Post

Treatments will change the pandemic, but they can’t end it alone A year after coronavirus vaccines dangled visions of an end to the pandemic, science has delivered inspiring results again: two antiviral pills that dramatically reduce the risk of hospitalization and death.

“We knew, given the political and social climate, that even once we had a vaccine our work was still cut out for us in terms of acceptability and uptake, so having the trials represent the people most impacted was really critical.”

Dr. Michele Andrasik discussed the importance of Black, Indigenous, and People Of Color (BIPOC) community engagement in vaccine trials. Read more from Cambridge Healthtech Institute: https://bit.ly/3HwBoZB

F.D.A. Clears First Coronavirus Vaccine for 5- to 11-Year-Olds The shot could bring relief to parents anxious about their children getting sick, though some experts worry that those most at risk may slip through the cracks.

Watch: What experts are saying about the future of COVID-19 in Washington state and beyond Drs. Larry Corey and Donna Hansel spoke with Benjamin Woodard of The Seattle Times about the course of the pandemic and what to expect this fall and winter. Hear what they say about boosters, variants, vaccine mandates and misinformation.

Here's how to know if you need a COVID booster shot and which one you can get A number of factors, including the vaccine you started with and when your last dose was, help determine when you qualify, according to the CDC.

Community engagement ensures equitable inclusion in vaccine trials Researchers from the COVID-19 Prevention Network have demonstrated that through robust community engagement, equitable inclusion in vaccine clinical trials can make a powerful impact in the health of underrepresented communities.

Using AI to identify potential COVID-19, cancer therapies Fred Hutch researchers are using machine learning and other AI tools to screen, identify and validate drug compounds that inhibit COVID-19's deadly cytokine storms, at least in mice and cells. Their AI drug discovery platform holds promise for identifying potential cancer therapies, too.

Ongoing trials test COVID-19 drugs for earlier, easier treatment At the COVID-19 Clinical Research Center on the Fred Hutch campus, people who recently received a positive test for SARS-CoV-2 are enrolled in trials of injectable antibodies and experimental antiviral drugs to see if these interventions may reduce the severity of symptoms and keep at risk patients....

Analysis: U.S. hopes COVID vaccine boosters will decrease not just deaths, but virus spread U.S. officials preparing to roll out COVID-19 booster shots in the face of waning vaccine protection and surging hospitalizations and deaths caused by the highly contagious Delta variant are hoping boosters might prevent mild cases as well.

Latest Fred Hutch research on COVID-19 Fred Hutch scientists have been on the forefront of research to understand the coronavirus and save lives through prevention and treatment. Read more about these studies and their most recent results.